%0 Journal Article
%T Sodium glucose co-transporter 2 inhibitors for glycemic control in type 2 diabetes mellitus: Quality of reporting of randomized controlled trials
%A Bikash Medhi
%A Harish Kumar
%A Niti Mittal
%A Rakesh Mittal
%J Archive of "Perspectives in Clinical Research".
%D 2016
%R 10.4103/2229-3485.173777
%X Sodium glucose co-transporter 2 inhibitors represent a novel class of antidiabetic drugs. The reporting quality of the trials evaluating the efficacy of these agents for glycemic control in type 2 diabetes mellitus has not been explored. Our aim was to assess the reporting quality of such randomized controlled trials (RCTs) and to identify the predictors of reporting quality
%K Consolidated Standards of Reporting Trials
%K diabetes mellitus
%K intention to treat
%K Jadad score
%K randomized controlled trials
%K sodium glucose co-transporter 2 inhibitors
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763513/